Indications and uses
Uses - helps prevent sunburn
No7 Men Protect and Perfect Intense Moisturiser
- Manufacturer
- BCM Ltd | The Boots Company PLC
- Effective date
- 2012-12-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:01
Label at a glance#
ProductNo7 Men Protect and Perfect Intense Moisturiser
Active ingredientAVOBENZONE, OCTISALATE, OCTOCRYLENE
Label structure15 sections
Dosage and administration
Directions for sunscreen use apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and eraly skin aging. Todecrease this risk, regularly use a sunscreen with a Broad spectrum SPF value of 15 or higher and ot...
Storage and handling
Other information - protect the product in this container from excessive heat and direct sun
Contacts and useful links#
Websitewww.boots.com
www.boots.com
www.boots.comLabel contents#
Full prescribing information#
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove
Ask a doctor
Stop use and ask a doctor if rash occurs
Keep out of reach of children
Keep out of reach of children. If swallowed, get medical help or contact a Poison Center right away
Directions
Directions for sunscreen use
apply liberally 15 minutes before sun exposure
reapply at least every 2 hours
use a water resistant sunscreen if swimming or sweating
children under 6 months of age: Ask a doctor
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and eraly skin aging. Todecrease this risk, regularly use a sunscreen with a Broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun,especially from 10 a.m. - 2 p.m.
wear long-sleeved shirts, pants,hats, and sunglasses
Storage
Other information - protect the product in this container from excessive heat and direct sun
Inactive ingredients
Aqua ( Water ), C12-15 alkyl benzoate, Glycerin, Dimethicone, Cetearyl glucoside, Aluminum starch octenylsuccinate, Tribehenin, Ammonium acryloydimethyltaurate/VP copolymer, Phenoxyethanol, Alcohol denat., Potassium cetyl phosphate, Cetearyl alcohol, Butylene glycol, Dimethiconol, Parfum ( Fragrance), Methylparaben,Ethylparaben, Xanthan gum, Retinyl palmitate, Ascorbyl glucoside, Sodium hyaluronate,Medicago sativa ( Alfalfa) extract, Tetrasodium EDTA, T-butyl-alcohol, Lupinus seed extract, Dipropylene glycol, carbomer, Phyllanthus emblica fruit extract, Dimethylmethoxy chromanol, Polysorbate 20, Potassium hydroxide, Ginkgo biloba leaf extract, Ethylhexylglycerin, Simethicone, Tocopherol, Palmitoyl oligopeptide, Palmitoyl tetrapeptide-7
Description
Feeling confident about your skin is critical. Protect and Perfect Intense Anti-Ageing Moisturiser combines the unique protecting and renewing ingredients found in our renowned Protect & Perfect Intense Anti-Ageing Serum with an intensively hydrating complex. Helps defend against premature ageing from UVA and UVB rays and boosts skin vitality when used as directed with other sun protection measures.
For Best Results: Use every morning on clean skin. Squeeze out a small amount into your palm and rub your hands together to leave an even amount on each. Smooth into your face and neck paying more attention to the drier areas. Use after applying Protect and Perfect Intense Anti-Ageing serum
Information
Made in the UK
The Boots Company PLC
Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc,
Norwalk CT 06851 USA
Carton Active Ingredients Section
Active Ingredients
Avobenzone 3%
Octisalate 3%
Octocrylene 4%
Purpose Sunscreen
Uses
Uses - helps prevent sunburn
airless bottle with pump
No7 Men Protect and Perfect Intense Moisturiser Sunscreen Broad Spectrum SPF 15
50ml e 1.69 US Fl.Oz.
Active ingredients: Avobenzone 3%, Octisalate 3%, Octocrylene 4%
Warning
Avoid contact with eyes. If product gets into the eyes rinse well with water immediately.
Description
For Best Results: Use every morning on clean skin. Squeeze out a small amount into your palm and rub your hands together to leave an even amount on each. Smooth into your face and neck paying more attention to the drier areas. Use after applying Protect and Perfect Intense Anti-Age serum. Helps protect against the ageing effects of the sun when used as directed with other sun protection measures.
Information
The Boots Company PLC
Nottingham England NG2 3AA
Dist by Boots Retail USA Inc.
Norwalk CT 06851 USA
Made in the UK
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
carton
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11489-079-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0fac-f424-e053-dadaa90a57ce | No7 Men Protect and Perfect Intense Moisturiser |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11489-079-01 | No7 Men Protect and Perfect Intense Moisturiser | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 11489-079-01 | No7 Men Protect and Perfect Intense Moisturiser | 50 g in 1 BOTTLE, PUMP | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| ALUMINUM STARCH OCTENYLSUCCINATE | INACTIVE INGREDIENT | I9PJ0O6294 | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| C12-15 ALKYL BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIMETHICONOL (100000 CST) | INACTIVE INGREDIENT | OSA9UP217S | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| LUPINUS ALBUS SEED | INACTIVE INGREDIENT | 24GB753W3B | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PHYLLANTHUS EMBLICA FRUIT | INACTIVE INGREDIENT | YLX4CW2576 | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Men Protect and Perfect Intense Moisturiser
- Avobenzone, Octisalate, Octocrylene
- AVOBENZONE
- OCTISALATE
- OCTOCRYLENE
- WATER
- C12-15 ALKYL BENZOATE
- GLYCERIN
- DIMETHICONE
- CETEARYL GLUCOSIDE
- ALUMINUM STARCH OCTENYLSUCCINATE
- TRIBEHENIN
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- PHENOXYETHANOL
- POTASSIUM CETYL PHOSPHATE
- CETOSTEARYL ALCOHOL
- BUTYLENE GLYCOL
- DIMETHICONOL (100000 CST)
- METHYLPARABEN
- ETHYLPARABEN
- XANTHAN GUM
- VITAMIN A PALMITATE
- ASCORBYL GLUCOSIDE
- EDETATE SODIUM
- LUPINUS ALBUS SEED
- DIPROPYLENE GLYCOL
- PHYLLANTHUS EMBLICA FRUIT
- POLYSORBATE 20
- POTASSIUM HYDROXIDE
- ETHYLHEXYLGLYCERIN
- TOCOPHEROL
- PALMITOYL OLIGOPEPTIDE
- PALMITOYL TETRAPEPTIDE-7
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11489-079 | 11489-079-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET / ORAL | 1.8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / VAGINAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / INTRAVASCULAR | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | 45 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAMUSCULAR | 95 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TAMPON / VAGINAL | 64.8 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SUSPENSION / ORAL | 8 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERIDURAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | TABLET / ORAL | 5 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IONTOPHORESIS | 0.1 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | 80 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | 1808 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAVENOUS | 0.13 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION / ORAL | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 15261ca5-1211-4dc5-a35b-47057c94c5c1 | 8cb4d728-d8b6-4dee-a208-31225a728b59 | 2012-12-10 | Warnings | 15261ca5-1211-4dc5-a35b-47057c94c5c1 8cb4d728-d8b6-4dee-a208-31225a728b59 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.